Rifampin oral capsules
Sponsors
GlaxoSmithKline, Amgen
Conditions
Healthy SubjectsNausea and Vomiting, Chemotherapy-Induced
Phase 1
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
CompletedNCT00405080
Start: 2006-11-11End: 2007-01-05Updated: 2017-09-12
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
CompletedNCT01561963
Start: 2012-02-01End: 2012-04-01Updated: 2021-06-09